<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31923209</article-id><article-id pub-id-type="pmc">6953880</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0227275</article-id><article-id pub-id-type="publisher-id">PONE-D-19-10189</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Helicobacter Pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Helicobacter Pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Helicobacter</subject><subj-group><subject>Helicobacter Pylori</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Motif Analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Gastrointestinal Tumors</subject><subj-group><subject>Gastric Cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Gastroenterology and Hepatology</subject><subj-group><subject>Gastrointestinal Infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Database and Informatics Methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence Analysis</subject><subj-group><subject>Sequence Alignment</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Co-Infections</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Bioinformatics</subject><subj-group><subject>Sequence analysis</subject><subj-group><subject>DNA sequence analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><italic>cagA</italic> gene EPIYA motif genetic characterization from Colombian <italic>Helicobacter pylori</italic> isolates: Standardization of a molecular test for rapid clinical laboratory detection</article-title><alt-title alt-title-type="running-head">Rapid detection of <italic>Helicobacter pylori</italic> EPIYA motifs</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5511-9402</contrib-id><name><surname>Rodr&#x000ed;guez G&#x000f3;mez</surname><given-names>Eliana Roc&#x000ed;o</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Otero Regino</surname><given-names>William</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Monterrey</surname><given-names>Pedro A.</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Trespalacios Rangel</surname><given-names>Alba Alicia</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Microbiology, Pontificia Universidad Javeriana, Bogot&#x000e1;, Colombia</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Gastroenterology Unit, Cl&#x000ed;nica Fundadores, Bogot&#x000e1;, Colombia</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>School of Natural Sciences and Mathematics, Universidad del Rosario, Bogot&#x000e1;, Colombia</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Ansumana</surname><given-names>Rashid</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Mercy Hospital, SIERRA LEONE</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>erodriguezg@javeriana.edu.co</email></corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>1</issue><elocation-id>e0227275</elocation-id><history><date date-type="received"><day>9</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Rodr&#x000ed;guez G&#x000f3;mez et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Rodr&#x000ed;guez G&#x000f3;mez et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0227275.pdf"/><abstract><p>The aim of this work was to determine current <italic>cagA</italic> gene EPIYA motifs present in Colombian <italic>Helicobacter pylori</italic> isolates using a fast and reliable molecular test. DNA from eighty-five <italic>Helicobacter pylori-cagA</italic> positive strains were analyzed. Strains were obtained from patients diagnosed with functional dyspepsia at Cl&#x000ed;nica Fundadores in Bogot&#x000e1;. The 3' region of the <italic>cagA</italic> gene was amplified through conventional Polymerase Chain Reaction (PCR). Obtained amplicons were sequenced using the Sanger method and analyzed with bioinformatics tools. Additionally, a significant Spearman correlation coefficient was determined between the patients' age and the number of EPIYA-C repeats; with <italic>p</italic> values &#x0003c; 0.05 considered significant. Estimates were obtained using a 95% CI. The 3&#x000b4; variable region of the <italic>cagA</italic> gene was amplified and PCR products of the following sizes corresponded to the following EPIYA motifs: 400 bp: EPIYA AB, 500 bp: EPIYA ABC, 600 bp: EPIYA ABCC and 700 bp: ABCCC. A single PCR band was observed for 58 out of 85 <italic>Helicobacter pylori</italic> isolates, with an EPIYA distribution motif as follows: 7/85 AB (8.2%), 34/85 ABC (40%), 26/85 ABCC (30.6%) and 18/85 ABCCC (21.2%). However, in 27 out of 85 <italic>Helicobacter pylori</italic> isolates, two or more bands were observed, where the most predominant <italic>cagA</italic> genotype were ABC-ABCC (26%, 7/27) and ABCC-ABCCC (22.2%, 6/27). A direct proportionality between the number of EPIYA-C repeats and an increase in the patients&#x02019; age was observed, finding a greater number of EPIYA ABCC and ABCCC repeats in the population over 50 years old. All isolates were of the Western <italic>cagA</italic> type and 51.8% of them were found to have multiple EPIYA-C repeats. These standardized molecular test allowed to identify the number of EPIYA C motifs based on band size.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100009543</institution-id><institution>Pontificia Universidad Javeriana</institution></institution-wrap></funding-source><award-id>6234</award-id><principal-award-recipient><name><surname>Trespalacios Rangel</surname><given-names>Alba Alicia</given-names></name></principal-award-recipient></award-group><funding-statement>The research reported in this manuscript has been funded by Pontificia Universidad Javeriana &#x02013; Vicerrectoria de Investigaci&#x000f3;n, Award number: Grant ID 6234. AATR received award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="5"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All date are available from the Harvard Dataverse (<ext-link ext-link-type="uri" xlink:href="https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP">https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP</ext-link>).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All date are available from the Harvard Dataverse (<ext-link ext-link-type="uri" xlink:href="https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP">https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP</ext-link>).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p><italic>Helicobacter pylori (H</italic>. <italic>pylori)</italic> bacteria infecting human gastric mucosa has been associated with development of gastroduodenal diseases, such as chronic gastritis, peptic and duodenal ulcer, MALT lymphoma and gastric cancer. Some populations displaying high infection prevalence, also present a high incidence of gastric cancer (East Asia). In contrast, this same relationship does not apply to Africa and South Asia. A plausible explanation for these differences might be due to <italic>H</italic>. <italic>pylori</italic> genetic plasticity, suggesting geographical differences in virulence genes [<xref rid="pone.0227275.ref001" ref-type="bibr">1</xref>]. However, gastric cancer is a multifactorial disease, where genetic and environmental factors, as well as <italic>H</italic>. <italic>pylori</italic> infection are involved. Some of the characteristics attributed to this microorganism are virulence factors, where the most studied and important is the CagA protein [<xref rid="pone.0227275.ref002" ref-type="bibr">2</xref>].</p><p><italic>cagA</italic> gene encodes a highly immunogenic and polymorphic protein (CagA). The protein is delivered into the gastric epithelial cells through the type IV secretion system. Once released within the cell, CagA is phosphorylated by the Src kinases family in EPIYA tyrosine residue motifs (Glu-Pro-Ile-Tyr-Ala), located in the carboxyl-terminal region [<xref rid="pone.0227275.ref003" ref-type="bibr">3</xref>].</p><p>After phosphorylation, CagA interacts with host proteins involved in signaling pathways, cell growth regulation, morphogenesis, cell motility and polarity, such as phosphatase SHP-2, an oncoprotein which has recently been found in a variety of human malignancies. The CagA-SHP-2 interaction activates the Erk MAP kinase cascade in dependent and independent ways, eliciting an epithelial cell morphological transformation, which leads to cell elongation (also known as the &#x0201c;Hummingbird phenotype&#x0201d;) [<xref rid="pone.0227275.ref004" ref-type="bibr">4</xref>]. In addition, Erk activation in epithelial cells also actives NF-Kb, which in turn induces interleukin-8 (IL-8) expression [<xref rid="pone.0227275.ref005" ref-type="bibr">5</xref>].</p><p>On the other hand, sustained SHP-2 activation induces apoptosis in gastric epithelial cells. However, CagA protein binding to the CSK kinase carboxyl-terminal region brings about down regulation, resulting in a CagA-SHP-2 complex decrease, contributing to dephosphorylation of other SRC substrate proteins, such as cortactin, a cytoskeletal protein that may be involved in morphological changes induced by CagA [<xref rid="pone.0227275.ref006" ref-type="bibr">6</xref>].</p><p>CagA variation in size is due to the EPIYA motif. Additionally, based on the number of amino acids and the flanking sequence of the motif, four types of EPIYA motifs have been described (A, B, C and D) [<xref rid="pone.0227275.ref007" ref-type="bibr">7</xref>]. A and B motifs are present in all isolates, whereas motif C is present in Western strains and motif D in Asian strains. EPIYA C motif presents different repeats, which are related with tyrosine phosphorylation levels. Therefore, Western CagA strains that have the highest EPIYA-C repeats are biologically more active than those with fewer repeats [<xref rid="pone.0227275.ref008" ref-type="bibr">8</xref>]. Accordingly, five studies have been conducted in order to assess the risk of developing gastric cancer based on the number of EPIYA-C repeats. Two of these studies were conducted in Europe [<xref rid="pone.0227275.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0227275.ref010" ref-type="bibr">10</xref>]. Based on the presence of two or more EPIYA-C repeats both studies reported the risk of developing gastric cancer was increased by 32 and 51-fold, respectively. The other three studies were conducted in America (Mexico) [<xref rid="pone.0227275.ref011" ref-type="bibr">11</xref>], (Brazil) [<xref rid="pone.0227275.ref012" ref-type="bibr">12</xref>] and (Colombia)[<xref rid="pone.0227275.ref013" ref-type="bibr">13</xref>], reporting the risks (OR) of developing gastric cancer increased by 5.9, 3.8 and 12-fold with the presence of the following repeats: 2 EPIYA-C, 2 and 3 EPIYA-C and 3-EPIYA-C, respectively. Additionally, to evaluate the association between EPIYA-C motif and gastric cancer risk a meta-analysis was performed. It was reported multiple EPIYA-C phosphorylation sites were associated with increased gastric cancer (OR: 2,95, 95%, <italic>P</italic> &#x0003c; .001). A subgroup analysis of different regions was performed finding in the South America, North American and Europe a significant association of multiple EPIYA-C motifs with cancer gastric (OR = 3.06, 95% CI: 2.29&#x02013;4.08, <italic>P</italic>&#x0003c;0.001; North America: OR = 4.59, 95% CI: 1.32&#x02013;15.94, <italic>P</italic> = 0.017; Europe: OR = 3.69, 95% CI: 1.98&#x02013;6.88, <italic>P</italic>&#x0003c;0.001 [<xref rid="pone.0227275.ref014" ref-type="bibr">14</xref>].</p><p>In contrast to EPIYA-C motif, EPIYA-D motif rarely duplicates; however, EPIYA-D consensus sequence exhibits greater SHP-2 binding activity, since there are no changes in amino acid sequences. On the other hand, EPIYA-C motif presents an amino acid sequence change at position pY+5. Therefore, EPIYA-D motif presents a stronger ability to induce stark changes in epithelial cells and a higher morphogenetic activity, when compared to EPIYA-C motif. Consequently CagA Asian strains tend to be more carcinogenic than CagA Western strains [<xref rid="pone.0227275.ref006" ref-type="bibr">6</xref>].</p><p>There are few studies that have described <italic>cagA</italic> gene EPIYA motifs genetic diversity present in <italic>H</italic>. <italic>pylori</italic> isolates from patients infected with chronic gastritis in Colombia. This information is very important to define <italic>H</italic>. <italic>pylori</italic> genetic diversity for this gene. Moreover, further studies could shed light on how these genetic differences and EPIYA motifs are related to gastric cancer onset. Current publications have focused on this diversity only in patients with gastric cancer. Hence, this information does not reflect the existing circulating diversity, which allows development of additional studies to assess the impact of <italic>cagA</italic> gene diversity on gastroduodenal diseases. To contribute with this understanding, this study aimed to determine current <italic>cagA</italic> gene EPIYA motifs circulation in Colombian <italic>H</italic>. <italic>pylori</italic> isolates through a rapid molecular test. In addition, the number of EPIYA motifs were classified according to the patients&#x02019; age to provide information regarding bacteria virulence and its possible relationship with gastric disease development.</p><p>Additionally, according to amplicon molecular weight this study allowed to determine the number of EPIYA motifs present in the <italic>cagA</italic> gene. This information will be very useful for gastroenterologists and clinicians to diagnose a patient by using accurate <italic>cagA</italic> gene information, thus determining if a patient infected with the bacteria could be at risk of developing gastric cancer. Furthermore, this technique spares the need of sequencing, making it a useful tool for clinicians to implement and confirm <italic>cagA</italic> infection phenotype.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><sec id="sec003"><title><italic>H</italic>. <italic>pylori</italic> isolates</title><p><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.17504/protocols.io.54jg8un">dx.doi.org/10.17504/protocols.io.54jg8un</ext-link></p><p>85 <italic>H</italic>. <italic>pylori</italic> strains <italic>cagA</italic> gene positive from Bogot&#x000e1;, Colombia were examined. <italic>H</italic>. <italic>pylori</italic> clinical isolates were obtained from patients diagnosed with functional dyspepsia at Cl&#x000ed;nica Fundadores in Bogot&#x000e1;, between 2009 and 2010. This study was approved by the Institutional Ethics Committees from Universidad Javeriana and Cl&#x000ed;nica Fundadores with signed informed consent from all patients.</p><p>Isolates were molecularly characterized and previously genotyped by our research group and were stored in the Collection of microorganisms at Pontificia Universidad Javeriana (CMPUJ) in Bogot&#x000e1;, Colombia.</p></sec><sec id="sec004"><title>PCR amplification and sequencing</title><p>The entire 3&#x000b4; repeat region for c<italic>agA</italic> gene was amplified by polymerase chain reaction (PCR) using <italic>cagA</italic> primers, sense (<monospace>CAGTF 5&#x02019;-ACCCTAGTCGGTAATGGG-3&#x02019;</monospace>) and antisense primers (<monospace>CAGTR 5&#x02019; GCTTTAGCTTCTGAYACYGC 3&#x02019;, Y: C + T</monospace>) position 2536 to 3044 [<xref rid="pone.0227275.ref015" ref-type="bibr">15</xref>] (GenBank accession number L11714). <italic>H</italic>. <italic>pylori</italic> reference strain (NCTC 11637, <italic>cagA</italic>-positive) was used as a positive control and <italic>H</italic>. <italic>pylori</italic> strain negative for <italic>cagA</italic> gene, <italic>Staphylococcus aureus</italic>, <italic>Salmonella typhi</italic> and <italic>Escherichia coli</italic> strains were used as a negative controls.</p><p>PCR amplification was carried out in a volume of 50 &#x003bc;L containing 0.3 &#x003bc;M primer concentration (Invitrogen, Carlsbad, CA, USA), 100 ng <italic>H</italic>. <italic>pylori</italic> genomic DNA and 1 U <italic>Taq</italic> DNA polymerase master mix (Promega, Madison, USA).</p><p>Polymerase chain reaction conditions included an initial denaturation step at 95&#x000b0;C/10 min, followed by 39 cycles (95&#x000b0;C/30 sec, 52.3&#x000b0;C/30 sec and 72&#x000b0;C/ 36 sec) and a final extension cycle at 72&#x000b0;C/5 min. PCR amplification was carried out in a Thermal cycler T100 (Biorad, Hercules, CA, USA). PCR products were visualized in 2% agarose gel electrophoresis with Syber Safe and photographed in Gel Doc<sup>XR+</sup> system (Biorad, Hercules, CA, USA) for analysis.</p><p>Samples which presented two or more bands in agarose gels from PCR amplifications (samples with mixed infection), were visualized using an UV transilluminator and cut. Each gel band with different sizes was placed in an Eppendorf tube and purified using Wizard SV Gel and PCR Clean-up System Kit (Promega, Madison, USA), according to the manufacturer&#x02019;s instructions. DNA concentration was determined by spectrophotometry using NanoDrop 2000 (Thermo Scientific, Wilmington, NC). DNA amplification obtained from gel bands was subsequently amplified by conventional PCR. Sequencing for PCR products and bioinformatic analysis were carried out to determine presence of EPIYA motifs in each sample, and to establish different strain types infecting each patient.</p><p>All PCR products from this study were sequenced at Universidad de Los Andes, Bogot&#x000e1;, Colombia. Sequencing reactions were carried out for both DNA strands (forward and reverse sense) by the Sanger method using as control <italic>H</italic>. <italic>pylori</italic> reference strain (NCTC 11637) sequence, which is Western <italic>cagA</italic> strain containing the EPIYA-ABC motif.</p></sec><sec id="sec005"><title>Bioinformatic analysis for sequences containing the EPIYA motif</title><p>Nucleotide sequences were aligned and analyzed using BLASTx, including <italic>H</italic>. <italic>pylori</italic> reference strain <italic>cagA</italic> sequences (NCTC 11637) (GenBank access AF202973).</p><p>The deduced peptide sequences containing EPIYA motifs were aligned employing CLUSTAL W (European Bioinformatics Institute <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/clustalw2/">http://www.ebi.ac.uk/Tools/clustalw2/</ext-link>).</p></sec><sec id="sec006"><title>Statistical analysis</title><p>Spearman correlation coefficient was calculated between the patients&#x02019; age and the number of EPIYA-C repeats, using a <italic>p</italic> value of less than 0.05 to establish significance. Estimation was obtained using a 95% CI, with a Bootstrap with 1,000 repetitions. The statistical processing was carried out in STATA 14.</p></sec></sec><sec sec-type="results" id="sec007"><title>Results</title><p><ext-link ext-link-type="uri" xlink:href="https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP">https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/KCZNKP</ext-link></p><sec id="sec008"><title>PCR amplification of <italic>cagA</italic> gene variable 3&#x02019; region</title><p><italic>cagA</italic> gene variable 3&#x02019; region coding for EPIYA motifs in 85 <italic>H</italic>. <italic>pylori</italic> isolates was amplified by using PCR. Products ranged in sizes between 400 bp and 700 bp. Based on this sizes, seven isolates displayed fragments of 400 bp, 34 isolates of 500 bp, 26 isolates of 600 bp and 18 isolates of 700 bp. Products were visualized in agarose gel electrophoresis. It was observed amplicons were equidistantly organized (100 bp) in a ladder-like arrangement, evidencing <italic>cagA</italic> gene 3&#x000b4; region size variation was due to presence of multiple EPIYA repeated sequences. DNA from the <italic>H</italic>. <italic>pylori</italic> reference strain (NCTC 11637) exhibited a single band with a size of 500 bp.</p><p>In 58 out of 85 (68.2%) <italic>H</italic>. <italic>pylori</italic> isolates, a single-band amplicon was observed, where PCR products ranged between 400 bp and 700 bp (<xref rid="pone.0227275.t001" ref-type="table">Table 1</xref>). However, in 27 out of 85 isolates (31.8%) two or more bands were present. Most of the isolates presented two bands with sizes ranging from 500, 600 and 700 bp (<xref rid="pone.0227275.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pone.0227275.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.t001</object-id><label>Table 1</label><caption><title>PCR product sizes of isolates with single-band.</title></caption><alternatives><graphic id="pone.0227275.t001g" xlink:href="pone.0227275.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Product size (bp)</th><th align="center" rowspan="1" colspan="1">Number of isolates</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">400</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">24</td></tr><tr><td align="center" rowspan="1" colspan="1">600</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td align="center" rowspan="1" colspan="1">700</td><td align="center" rowspan="1" colspan="1">14</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0227275.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.t002</object-id><label>Table 2</label><caption><title>PCR products of isolates with two or more bands.</title></caption><alternatives><graphic id="pone.0227275.t002g" xlink:href="pone.0227275.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Number of isolates</th><th align="center" rowspan="1" colspan="1">Number of bands</th><th align="center" rowspan="1" colspan="1">Product size (bp)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">500&#x02013;600</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">600&#x02013;700</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">400&#x02013;500</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">400-500-600</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">500-600-700</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">400-500-700</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">400-500-600-700</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec009"><title>EPIYA motif bioinformatic analysis in <italic>H</italic>. <italic>pylori</italic> clinical isolates</title><p>Based on CLUSTAL W peptide sequence alignment it was observed all sequenced <italic>cagA</italic> variable regions corresponded to the Western type, with three EPIYA motifs: <monospace>EPIYA-A: <underline>EPIYA</underline>KVNKKKAGQ; EPIYA-B: <underline>EPIY(A/T)</underline>QVAKKVNAKI</monospace> and <monospace>EPIYA-C: <underline>EPIYA</underline>TIDDLGGP</monospace>. From the population studied no strain corresponded to the <monospace>EPIYA-D</monospace> Eastern type: <monospace><underline>EPIYA</underline>TIDFDEANQAG</monospace> (<xref ref-type="fig" rid="pone.0227275.g001">Fig 1</xref>). Total distribution of EPIYA motif in isolates was: 7/85 AB (8.2%), 34/85 ABC (40%), 26/85 ABCC (30.6%) and 18/85 ABCCC (21.2%) (<xref ref-type="fig" rid="pone.0227275.g002">Fig 2</xref>).</p><fig id="pone.0227275.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.g001</object-id><label>Fig 1</label><caption><title>3&#x000b4;<italic>cagA</italic> region amino acid sequence alignment for five Colombian <italic>H</italic>. <italic>pylori</italic> isolates.</title><p>EPIYA motifs: A (red), B (purple), one C (blue), two C (green), three C (yellow). <italic>H</italic>. <italic>pylori</italic> reference strain (NCTC 11637) contained the EPIYA-ABC motif, strains 24C (AB), strain 358A (ABCC), strains 2C and 25A (ABCCC).</p></caption><graphic xlink:href="pone.0227275.g001"/></fig><fig id="pone.0227275.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.g002</object-id><label>Fig 2</label><caption><title>Total distribution of EPIYA motif in Colombian <italic>H</italic>. <italic>pylori</italic> isolates.</title><p>EPIYA-motif in the CagA protein C-terminal region and their frequency in Colombian <italic>H</italic>. <italic>pylori</italic> isolates included in this study. The EPIYA motif with one C (blue), two Cs (green) and three Cs (yellow) are shown.</p></caption><graphic xlink:href="pone.0227275.g002"/></fig></sec><sec id="sec010"><title>Analysis of the <italic>cagA</italic> EPIYA-C repeat number according to band size by rapid molecular test</title><p>EPIYA C repeat number prediction based on PCR amplicon size was confirmed by sequencing. To this end, first standardization of conventional PCR was carried-out to amplify the fragment containing EPIYA motifs. Following, each band obtained in the PCR process was cut and sequenced, identifying that all 400 bp PCR products corresponded to EPIYA AB, 500 bp to EPIYA ABC, 600 bp to EPIYA ABCC and 700 bp to EPIYA ABCCC (<xref ref-type="fig" rid="pone.0227275.g003">Fig 3</xref>), with the following distribution: 7/85 isolates with 400 bp product size were EPIYA AB, 34/85 500 bp isolates were EPIYA-ABC, 26/85 isolates with 600 bp products were EPIYA-ABCC and 18/85 isolates with 700 bp were EPIYA-ABCCC (<xref rid="pone.0227275.t003" ref-type="table">Table 3</xref>).</p><fig id="pone.0227275.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.g003</object-id><label>Fig 3</label><caption><title>Association between PCR amplicons size and EPIYA motif.</title><p>DNA from <italic>H</italic>. <italic>pylori</italic> isolates (lanes 3&#x02013;12) were amplified and PCR products were visualized in a 2% agarose gel. The following PCR products are illustrated: 400 bp (EPIYA AB), 500 bp (EPIYA ABC), 600 bp (EPIYA ABCC) and 700 bp (EPIYA ABCCC). Lane 2: negative control, lane 12: NCTC 11637, Lane 1: 100 bp DNA ladder (Promega, USA).</p></caption><graphic xlink:href="pone.0227275.g003"/></fig><table-wrap id="pone.0227275.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.t003</object-id><label>Table 3</label><caption><title>PCR amplicons size and EPIYA motif distribution.</title></caption><alternatives><graphic id="pone.0227275.t003g" xlink:href="pone.0227275.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Product size (bp)</th><th align="center" rowspan="1" colspan="1">EPIYA motif</th><th align="center" rowspan="1" colspan="1">Number of isolates</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">400</td><td align="center" rowspan="1" colspan="1">AB</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1">ABC</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="center" rowspan="1" colspan="1">600</td><td align="center" rowspan="1" colspan="1">ABCC</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="center" rowspan="1" colspan="1">700</td><td align="center" rowspan="1" colspan="1">ABCCC</td><td align="center" rowspan="1" colspan="1">18</td></tr></tbody></table></alternatives></table-wrap><p>Furthermore, presence of single and multiple <italic>cagA</italic> EPIYA genotypes was observed in patients included in this study. In 58 patients no co-infection was identified and the following EPIYA distribution was observed: 2/58 had the AB motif (3.5%), 24/58 had the ABC (41.4%), 18/58 had the ABCC (31%) and 14/58 had the ABCCC (24.1%) (<xref rid="pone.0227275.t004" ref-type="table">Table 4</xref>). 27 patients were infected with two or more different <italic>cagA</italic> EPIYA genotypes. Co-infection with two EPIYA genotypes was detected as follows: ABC and ABCC were observed in 7 patients; ABCC and ABCCC in 6 patients and AB and ABC in 5 patients. Additionally, co-infection with three and four EPIYA genotypes was also observed. Concomitant genotypes with three different motifs were observed as follows: AB, ABC and ABCC in five patients; AB, ABC and ABCCC in one patient; ABC, ABCC and ABCCC in one patient and last, two patients had coinfection with strains with the following EPIYA genotypes: AB, ABC, ABCC and ABCCC (<xref rid="pone.0227275.t005" ref-type="table">Table 5</xref>).</p><table-wrap id="pone.0227275.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.t004</object-id><label>Table 4</label><caption><title><italic>cagA</italic> EPIYA genotypes in patient isolates without mixed infection.</title></caption><alternatives><graphic id="pone.0227275.t004g" xlink:href="pone.0227275.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Number of isolates</th><th align="center" rowspan="1" colspan="1">EPIYA motif type</th><th align="center" rowspan="1" colspan="1">EPIYA motif %</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">AB</td><td align="center" rowspan="1" colspan="1">3.5</td></tr><tr><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">ABC</td><td align="center" rowspan="1" colspan="1">41.4</td></tr><tr><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">ABCC</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">ABCCC</td><td align="center" rowspan="1" colspan="1">24.1</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone.0227275.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.t005</object-id><label>Table 5</label><caption><title><italic>cagA</italic> EPIYA genotypes in patient isolates with coinfection.</title></caption><alternatives><graphic id="pone.0227275.t005g" xlink:href="pone.0227275.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Number of isolates</th><th align="center" rowspan="1" colspan="1">EPIYA motif combination</th><th align="center" rowspan="1" colspan="1">EPIYA motif combination %</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">AB-ABC</td><td align="center" rowspan="1" colspan="1">18.5</td></tr><tr><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">ABC-ABCC</td><td align="center" rowspan="1" colspan="1">26</td></tr><tr><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">ABCC-ABCCC</td><td align="center" rowspan="1" colspan="1">22.2</td></tr><tr><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">AB-ABC-ABCC</td><td align="center" rowspan="1" colspan="1">18.5</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">AB-ABC-ABCCC</td><td align="center" rowspan="1" colspan="1">3.7</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">AB-ABCC-ABCCC</td><td align="center" rowspan="1" colspan="1">3.7</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">AB-ABC-ABCC-ABCCC</td><td align="center" rowspan="1" colspan="1">7.4</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec011"><title>Correlation between EPIYA-C repeats and patients&#x02019; age</title><p>For the 85 isolates Spearman correlation coefficient between the patients&#x02019; age and the total number of EPIYA-C repeats was 0.822, suggesting a direct proportionality between the number of EPIYA-C repeats and an increase in the patients&#x02019; age (<xref ref-type="fig" rid="pone.0227275.g004">Fig 4</xref>). The following was concluded from the statistical analysis: patients without coinfection with one EPIYA-C repeat on average were 45 years old, two EPIYA-C repeats had on an average 51 years, and with three EPIYA-C repeats on average had an age of 63 years. A significant correlation was observed between increase in the patients&#x02019; age and the number of EPIYA-C repeats (<italic>P</italic> &#x0003c; 0.05).</p><fig id="pone.0227275.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0227275.g004</object-id><label>Fig 4</label><caption><title>Correlation between patients&#x02019; age and the number of EPIYA-C repeats.</title><p>Total number of EPIYA C repeats in 85 isolates from patients infected with <italic>H</italic>. <italic>pylori</italic> and patients&#x02019; age.</p></caption><graphic xlink:href="pone.0227275.g004"/></fig></sec></sec><sec sec-type="conclusions" id="sec012"><title>Discussion</title><p>All isolates included in this study were of the Western <italic>cagA</italic> gene type. No Eastern type isolates circulating within our population were found, which is agreement with studies also included Colombian patient isolates [<xref rid="pone.0227275.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pone.0227275.ref017" ref-type="bibr">17</xref>]. Furthermore, studies in Europe, America and Africa also reported the Western <italic>cagA</italic> gene type [<xref rid="pone.0227275.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0227275.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0227275.ref020" ref-type="bibr">20</xref>].</p><p>Presence of <italic>cagA</italic> gene with one to three EPIYA-C repeats from <italic>H</italic>. <italic>pylori</italic> isolates were observed, which were found to contain EPIYA ABC segments in 40% of <italic>H</italic>. <italic>pylori</italic> isolates (<xref ref-type="fig" rid="pone.0227275.g002">Fig 2</xref>). These results are similar the one reported in other studies [<xref rid="pone.0227275.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0227275.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0227275.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0227275.ref021" ref-type="bibr">21</xref>]. However, the frequency of isolates containing a <italic>cagA</italic> gene with two or three EPIYA-C repeats was 51.8%, a higher percentage than the one reported in studies from Colombia [<xref rid="pone.0227275.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0227275.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0227275.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0227275.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0227275.ref022" ref-type="bibr">22</xref>]. Differences might be accounted by the fact that previous studies included patients with different diseases (atrophic gastritis, ulcers, cancer), unlike the present study where circulation of isolates with multiple EPIYA-C was described only from patients with chronic gastritis.</p><p>Likewise, to determine the prevalence of isolates with multiple EPIYA-C motifs in other countries, different studies have been carried-out. Fewer isolates with multiple EPIYA-C have been reported in France (32%)[<xref rid="pone.0227275.ref022" ref-type="bibr">22</xref>], Costa Rica (30.3%)[<xref rid="pone.0227275.ref023" ref-type="bibr">23</xref>], South Africa (27%)[<xref rid="pone.0227275.ref020" ref-type="bibr">20</xref>], Greece (21%) [<xref rid="pone.0227275.ref024" ref-type="bibr">24</xref>], Cuba (22.1%) [<xref rid="pone.0227275.ref025" ref-type="bibr">25</xref>], Mexico (20%) [<xref rid="pone.0227275.ref026" ref-type="bibr">26</xref>], USA (17%) [<xref rid="pone.0227275.ref022" ref-type="bibr">22</xref>] and Peru (11.5%) [<xref rid="pone.0227275.ref019" ref-type="bibr">19</xref>] in comparison with those found in this study. This might be due to the process of <italic>cagA</italic> microevolution, which describes a genetic change that leads to a modification in virulence factors, representing important implications in <italic>H</italic>. <italic>pylori</italic> pathogenesis [<xref rid="pone.0227275.ref027" ref-type="bibr">27</xref>,<xref rid="pone.0227275.ref028" ref-type="bibr">28</xref>]. This might explain in part the greater number of EPIYA-C in patients with chronic gastritis in this study, but the relationship between bacterial virulence and disease did not show a strict association. Additionally, another possible cause for results observed in this study is the populations studied. Previous studies included patients with different gastrointestinal diseases (gastritis, ulcers, metaplasia, dysplasia, cancer) with a variation in the sample size and possibly, gastric cancer incidence for each country. It is noteworthy that Colombia has a higher incidence of gastric cancer in comparison with other countries, possibly due in part to multiple EPIYA-C repeats. Western CagA proteins with two or more EPIYA-C repeats are more virulent and associated with a high gastric cancer risk than isolates with only one EPIYA-C motif [<xref rid="pone.0227275.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0227275.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0227275.ref025" ref-type="bibr">25</xref>]. Moreover, the risk of gastric cancer is 12 times higher in patients infected with three EPIYA-C repeats than in patients infected with one EPIYA-C motif [<xref rid="pone.0227275.ref013" ref-type="bibr">13</xref>].</p><p>The results of this study showed a significant association between the increase in patients&#x02019; age and the EPIYA repeats observed (<xref ref-type="fig" rid="pone.0227275.g004">Fig 4</xref>). Gastric cancer is uniformly rare in adults aged &#x0003c;50 years and frequently occurs in an age range between 55&#x02013;80 years, in younger patients it is unusual [<xref rid="pone.0227275.ref029" ref-type="bibr">29</xref>]. Likewise, the International Agency for Research on Cancer (IARC) and World Health Organization (WHO) (2008) reported the mortality of gastric cancer increased with advancing age. They reported 245 deaths occur in patients between the ages of 40&#x02013;49 years old, 479 deaths in patients aged between 50&#x02013;59 years old and 687 deaths in patients aged 60&#x02013;69 years old. Thus, suggesting in the present study patients between 50&#x02013;70 years old, who presented two and three EPIYA-C repeats, might be at increased risk of developing gastric cancer rather than under 50 years who had one or no EPIYA C motif. These results agree with those reported in Iraqi patient isolates [<xref rid="pone.0227275.ref030" ref-type="bibr">30</xref>], where the average age of patients infected with EPIYA ABCC and ABCCC was higher than in patients who had other types of EPIYA motifs, finding the following EPIYA distribution related to the average age in patients: EPIYA ABC- 45 years, EPIYA ABCC- 51 years and EPIYA ABCCC- 63 years. However, they included different pathologies, not only chronic gastritis.</p><p>According to estimates from the International Agency for Research on Cancer (IARC) GLOBOCAN project, worldwide there were 1,033,701 new cases of gastric cancer and 782,685 deaths related to gastric cancer in 2018 [<xref rid="pone.0227275.ref031" ref-type="bibr">31</xref>]. Additionally, about 40% of patients with gastric cancer do not report symptoms before diagnosis, prevention becomes the best strategy to control gastric cancer. A program to prevent gastric cancer should include: detecting <italic>H</italic>. <italic>pylori</italic>, surveillance of precancerous lesions by endoscopic and histological studies, improve sanitation and hygiene, restrict salt consumption in the diet, and eat a balanced and rich diet containing fruits and fresh vegetables, with plenty of antioxidants [<xref rid="pone.0227275.ref032" ref-type="bibr">32</xref>]. Since more than 80% of cases of gastric cancer have been attributed to <italic>H</italic>. <italic>pylori</italic> infection [<xref rid="pone.0227275.ref033" ref-type="bibr">33</xref>], eradication is considered a primary prevention strategy.</p><p>According to the Maastricht V consensus [<xref rid="pone.0227275.ref034" ref-type="bibr">34</xref>], <italic>H</italic>. <italic>pylori</italic> eradication reduces the risk of developing gastric cancer. Therefore, patients should be treated during the initial phase of infection, before pre-neoplastic changes develop in the gastric mucosa. Furthermore, to reduce the risk of gastric cancer consensus statements suggested an eradication therapy should be offered to family members that have a first consanguinity degree of gastric cancer patients, patients with previous gastric neoplastic that have already been treated by endoscopic or gastric resection subtotal, patients with a risk of severe pangastritis, corpus predominant gastritis or severe atrophy and patients with chronic inhibition of gastric acid for more than one year. Two other documents, one written by the American College of Gastroenterology and the other by the Asia and Pacific consensus, also recommended <italic>H</italic>. <italic>pylori</italic> eradication in patients with endoscopic resection of early gastric cancer in regions with annual incidence of gastric cancer with a population above 20/100,000 [<xref rid="pone.0227275.ref035" ref-type="bibr">35</xref>].</p><p>In this study, 27 isolates with two or more bands with sizes corresponding to different numbers of EPIYA-C repeats were found (<xref rid="pone.0227275.t002" ref-type="table">Table 2</xref>). This is probably due to sub-clone presence with high rates of plastic recombination with <italic>H</italic>. <italic>pylori</italic> genome, emerging from microevolution processes or to co-infection with multiple <italic>H</italic>. <italic>pylori</italic> strains that coexist in the same patient [<xref rid="pone.0227275.ref036" ref-type="bibr">36</xref>], also may be due to that <italic>H</italic>. <italic>pylori</italic> isolates from gastric biopsies is often made by the sweeping method instead of individual colony selection [<xref rid="pone.0227275.ref024" ref-type="bibr">24</xref>]; hence, presence of multiple <italic>cagA</italic> genotypes in the same patient was observed.</p><p>With respect to the methodological strategy used in this study, PCR amplification allowed to establish the number of EPIYA repeats, according to PCR product size and number of bands (<xref ref-type="fig" rid="pone.0227275.g003">Fig 3</xref>), which was further confirmed by sequencing. This method permitted to predict with precision each of the bands specific for <italic>cagA</italic> sequences, in addition to the presence of co-infection with different <italic>cagA</italic> genotypes. Therefore, its implementation can be very useful in hospital laboratories. Furthermore, this technique does not require sequencing, and represents a useful tool for clinical implementation, thus helping to confirm CagA phenotype infection.</p><p>Other methodologies, such as design specific primers for Western <italic>cagA</italic>, Oriental <italic>cagA</italic>, EPIYA-A, B and C repeats and sequencing have been previously reported [<xref rid="pone.0227275.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0227275.ref025" ref-type="bibr">25</xref>]. These strategies also detect strains with more than one EPIYA motif in the same patient, namely mixed infection or co-infection but the disadvantage of these methods include a longer processing time and higher costs.</p></sec><sec sec-type="conclusions" id="sec013"><title>Conclusion</title><p>In this study, it was identified that all Colombian <italic>H</italic>. <italic>pylori</italic> isolates contained the Western <italic>cagA</italic> gene type, with a predominant EPIYA-ABC and multiple EPIYA-C repeats. EPIYA-ABCC and EPIYA-ABCCC were present in 52% of the infected population, indicating that <italic>H</italic>. <italic>pylori cagA</italic> positive isolates have a high virulence potential and therefore, these strains could be involved in a higher risk of gastric cancer development. In the population over 50 years old a greater number of EPIYA ABCC and ABCCC motifs was observed, moreover mixed infection with strains with different EPIYA C was frequent. Taking into account that the objective of our study was to determine current c<italic>agA</italic> gen circulation present in EPIYA motifs, justifying why only genomics was performed in this study. EPIYA motifs genotype not necessarily imply a permanent expression. Therefore, we suggest for future studies to perform transcriptomics or carry-out an <italic>in vivo</italic> approximation at the mucosa level, assay translocation and tyrosine CagA phosphorylation, IL-8 secretion and cell elongation induction, which would allow us more comprehensively to understand the mixed infection with different EPIYA motif and clinical significance.</p><p>Standardized molecular biology tests in this study are easy to carry-out and according to the band size allow to determine the number of EPIYA C motifs repeats. This method can be easily implemented in hospitals and contribute with <italic>cagA</italic> genotyping in Colombia. Furthermore, it will be a useful tool for gastroenterologists to better assess patients infected with <italic>H</italic>. <italic>pylori</italic> and the risk of developing gastric cancer.</p></sec></body><back><ack><p>Authors thank Dr. Guillermo P&#x000e9;rez-P&#x000e9;rez from New York University for his recommendations on the methodology presented in this study and Dr. Mar&#x000ed;a Luc&#x000ed;a Guti&#x000e9;rrez G&#x000f3;mez for the English editing.</p></ack><ref-list><title>References</title><ref id="pone.0227275.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Hayashi</surname><given-names>T</given-names></name>, <name><surname>Senda</surname><given-names>M</given-names></name>, <name><surname>Suzuki</surname><given-names>N</given-names></name>, <name><surname>Nishikawa</surname><given-names>H</given-names></name>, <name><surname>Ben</surname><given-names>C</given-names></name>, <name><surname>Tang</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Differential mechanisms for SHP2 binding and activation are exploited by geographically distinct <italic>Helicobacter pylori</italic> CagA Oncoproteins</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>: <fpage>2876</fpage>&#x02013;<lpage>2890</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.080</pub-id>
<pub-id pub-id-type="pmid">28930683</pub-id></mixed-citation></ref><ref id="pone.0227275.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Piazuelo</surname><given-names>MB</given-names></name>, <name><surname>Epplein</surname><given-names>M</given-names></name>, <name><surname>Correa</surname><given-names>P</given-names></name>. <article-title>Gastric cancer: an infectious disease</article-title>. <source>Infect Dis Clin North Am</source>. <year>2010</year>;<volume>24</volume>: <fpage>853</fpage>&#x02013;<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1016/j.idc.2010.07.010</pub-id>
<pub-id pub-id-type="pmid">20937454</pub-id></mixed-citation></ref><ref id="pone.0227275.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Hatakeyama</surname><given-names>M</given-names></name>. <article-title>Anthropological and clinical implications for the structural diversity of the <italic>Helicobacter pylori</italic> CagA oncoprotein</article-title>. <source>Cancer Sci</source>. <year>2011</year>;<volume>102</volume>: <fpage>36</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2010.01743.x</pub-id>
<pub-id pub-id-type="pmid">20942897</pub-id></mixed-citation></ref><ref id="pone.0227275.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Higashi</surname><given-names>H.</given-names></name>
<article-title>SHP-2 tyrosine phosphatase as an intracellular target of <italic>Helicobacter pylori</italic> CagA Protein</article-title>. <source>Science</source> (80-). <year>2002</year>;<volume>295</volume>: <fpage>683</fpage>&#x02013;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1126/science.1067147</pub-id>
<pub-id pub-id-type="pmid">11743164</pub-id></mixed-citation></ref><ref id="pone.0227275.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Brandt</surname><given-names>S</given-names></name>, <name><surname>Kwok</surname><given-names>T</given-names></name>, <name><surname>Hartig</surname><given-names>R</given-names></name>, <name><surname>Konig</surname><given-names>W</given-names></name>, <name><surname>Backert</surname><given-names>S</given-names></name>. <article-title>NF- B activation and potentiation of proinflammatory responses by the <italic>Helicobacter pylori</italic> CagA protein</article-title>. <source>Proc Natl Acad Sci</source>. <year>2005</year>;<volume>102</volume>: <fpage>9300</fpage>&#x02013;<lpage>9305</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0409873102</pub-id>
<pub-id pub-id-type="pmid">15972330</pub-id></mixed-citation></ref><ref id="pone.0227275.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Hatakeyama</surname><given-names>M</given-names></name>, <name><surname>Higashi</surname><given-names>H</given-names></name>. <article-title><italic>Helicobacter pylori</italic> CagA: a new paradigm for bacterial carcinogenesis</article-title>. <source>Cancer Sci</source>. <year>2005</year>;<volume>96</volume>: <fpage>835</fpage>&#x02013;<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2005.00130.x</pub-id>
<pub-id pub-id-type="pmid">16367902</pub-id></mixed-citation></ref><ref id="pone.0227275.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Higashi</surname><given-names>H</given-names></name>, <name><surname>Tsutsumi</surname><given-names>R</given-names></name>, <name><surname>Fujita</surname><given-names>A</given-names></name>, <name><surname>Yamazaki</surname><given-names>S</given-names></name>, <name><surname>Asaka</surname><given-names>M</given-names></name>, <name><surname>Azuma</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Biological activity of the <italic>Helicobacter pylori</italic> virulence factor CagA is determined by variation in the tyrosine phosphorylation sites</article-title>. <source>Proc Natl Acad Sci</source>. <year>2002</year>;<volume>99</volume>: <fpage>14428</fpage>&#x02013;<lpage>14433</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.222375399</pub-id>
<pub-id pub-id-type="pmid">12391297</pub-id></mixed-citation></ref><ref id="pone.0227275.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Yamaoka</surname><given-names>Y</given-names></name>, <name><surname>Zhu</surname><given-names>Q</given-names></name>, <name><surname>Matha</surname><given-names>I</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>. <article-title>A comprehensive sequence and disease correlation analyses for the C-Terminal region of CagA protein of <italic>Helicobacter pylori</italic></article-title>. <source>Ahmed N</source>, editor. PLoS One. <year>2009</year>;<volume>4</volume>: <fpage>e7736</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0007736</pub-id>
<pub-id pub-id-type="pmid">19893742</pub-id></mixed-citation></ref><ref id="pone.0227275.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Basso</surname><given-names>D</given-names></name>, <name><surname>Zambon</surname><given-names>C</given-names></name>, <name><surname>Letley</surname><given-names>DP</given-names></name>, <name><surname>Stranges</surname><given-names>A</given-names></name>, <name><surname>Marchet</surname><given-names>A</given-names></name>, <name><surname>Rhead</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Clinical relevance of <italic>Helicobacter pylori cagA</italic> and <italic>vacA</italic> gene polymorphisms</article-title>. <source>Gastroenterology</source>. <year>2008</year>;<volume>135</volume>: <fpage>91</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2008.03.041</pub-id>
<pub-id pub-id-type="pmid">18474244</pub-id></mixed-citation></ref><ref id="pone.0227275.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ferreira</surname><given-names>RM</given-names></name>, <name><surname>Machado</surname><given-names>JC</given-names></name>, <name><surname>Leite</surname><given-names>M</given-names></name>, <name><surname>Carneiro</surname><given-names>F</given-names></name>, <name><surname>Figueiredo</surname><given-names>C</given-names></name>. <article-title>The number of <italic>Helicobacter pylori</italic> CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma</article-title>. <source>Histopathology</source>. <year>2012</year>;<volume>60</volume>: <fpage>992</fpage>&#x02013;<lpage>998</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2559.2012.04190.x</pub-id>
<pub-id pub-id-type="pmid">22348604</pub-id></mixed-citation></ref><ref id="pone.0227275.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Beltr&#x000e1;n-Anaya</surname><given-names>FO</given-names></name>, <name><surname>Poblete</surname><given-names>TM</given-names></name>, <name><surname>Rom&#x000e1;n-Rom&#x000e1;n</surname><given-names>A</given-names></name>, <name><surname>Reyes</surname><given-names>S</given-names></name>, <name><surname>de Sampedro</surname><given-names>J</given-names></name>, <name><surname>Peralta-Zaragoza</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>The EPIYA-ABCC motif pattern in CagA of <italic>Helicobacter pylori</italic> is associated with peptic ulcer and gastric cancer in Mexican population</article-title>. <source>BMC Gastroenterol</source>. <year>2014</year>;<volume>14</volume>: <fpage>223</fpage>
<pub-id pub-id-type="doi">10.1186/s12876-014-0223-9</pub-id>
<pub-id pub-id-type="pmid">25539656</pub-id></mixed-citation></ref><ref id="pone.0227275.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Batista</surname><given-names>SA</given-names></name>, <name><surname>Rocha</surname><given-names>GA</given-names></name>, <name><surname>Rocha</surname><given-names>AM</given-names></name>, <name><surname>Saraiva</surname><given-names>IE</given-names></name>, <name><surname>Cabral</surname><given-names>MM</given-names></name>, <name><surname>Oliveira</surname><given-names>RC</given-names></name>, <etal>et al</etal>
<article-title>Higher number of <italic>Helicobacter pylori</italic> CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer</article-title>. <source>BMC Microbiol</source>. <year>2011</year>;<volume>11</volume>: <fpage>61</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-11-61</pub-id>
<pub-id pub-id-type="pmid">21435255</pub-id></mixed-citation></ref><ref id="pone.0227275.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Quiroga</surname><given-names>AJ</given-names></name>, <name><surname>Huertas</surname><given-names>A</given-names></name>, <name><surname>C&#x000f3;mbita</surname><given-names>AL</given-names></name>, <name><surname>Bravo</surname><given-names>MM</given-names></name>. <article-title>Variaci&#x000f3;n en el n&#x000fa;mero de repeticiones EPIYA-C en la prote&#x000ed;na CagA de aislamientos colombianos de <italic>Helicobacter pylori</italic> y su capacidad para inducir fenotipo colibr&#x000ed; en c&#x000e9;lulas epiteliales g&#x000e1;stricas</article-title>. <source>Biom&#x000e9;dica</source>. <year>2010</year>;<volume>30</volume>: <fpage>251</fpage>
<pub-id pub-id-type="doi">10.7705/biomedica.v30i2.188</pub-id>
<pub-id pub-id-type="pmid">20890572</pub-id></mixed-citation></ref><ref id="pone.0227275.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>Y</given-names></name>, <name><surname>Yuan</surname><given-names>Y</given-names></name>. <article-title>Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks</article-title>. <source>Medicine (Baltimore)</source>. <year>2017</year>;<volume>96</volume>: <fpage>e6620</fpage>
<pub-id pub-id-type="doi">10.1097/MD.0000000000006620</pub-id>
<pub-id pub-id-type="pmid">28445260</pub-id></mixed-citation></ref><ref id="pone.0227275.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Yamaoka</surname><given-names>Y</given-names></name>, <name><surname>El&#x02013;Zimaity</surname><given-names>HMT</given-names></name>, <name><surname>Gutierrez</surname><given-names>O</given-names></name>, <name><surname>Figura</surname><given-names>N</given-names></name>, <name><surname>Kim</surname><given-names>JK</given-names></name>, <name><surname>Kodama</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Relationship between the cagA 3&#x02019; repeat region of <italic>Helicobacter pylori</italic>, gastric histology, and susceptibility to low pH</article-title>. <source>Gastroenterology</source>. <year>1999</year>;<volume>117</volume>: <fpage>342</fpage>&#x02013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1053/gast.1999.0029900342</pub-id>
<pub-id pub-id-type="pmid">10419915</pub-id></mixed-citation></ref><ref id="pone.0227275.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Schneider</surname><given-names>N</given-names></name>, <name><surname>Krishna</surname><given-names>U</given-names></name>, <name><surname>Romero&#x02010;Gallo</surname><given-names>J</given-names></name>, <name><surname>Israel</surname><given-names>DA</given-names></name>, <name><surname>Piazuelo</surname><given-names>MB</given-names></name>, <name><surname>Camargo</surname><given-names>MC</given-names></name>, <etal>et al</etal>
<article-title>Role of <italic>Helicobacter pylori</italic> CagA molecular variations in induction of host phenotypes with carcinogenic potential</article-title>. <source>J Infect Dis</source>. <year>2009</year>;<volume>199</volume>: <fpage>1218</fpage>&#x02013;<lpage>1221</lpage>. <pub-id pub-id-type="doi">10.1086/597416</pub-id>
<pub-id pub-id-type="pmid">19278338</pub-id></mixed-citation></ref><ref id="pone.0227275.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Fajardo</surname><given-names>CA</given-names></name>. <article-title>CagA EPIYA polymorphisms in Colombian <italic>Helicobacter pylori</italic> strains and their influence on disease-associated cellular responses</article-title>. <source>World J Gastrointest Oncol</source>. <year>2013</year>;<volume>5</volume>: <fpage>50</fpage>
<pub-id pub-id-type="doi">10.4251/wjgo.v5.i3.50</pub-id>
<pub-id pub-id-type="pmid">23671731</pub-id></mixed-citation></ref><ref id="pone.0227275.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Argent</surname><given-names>RH</given-names></name>, <name><surname>Kidd</surname><given-names>M</given-names></name>, <name><surname>Owen</surname><given-names>RJ</given-names></name>, <name><surname>Thomas</surname><given-names>RJ</given-names></name>, <name><surname>Limb</surname><given-names>MC</given-names></name>, <name><surname>Atherton</surname><given-names>JC</given-names></name>. <article-title>Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of <italic>Helicobacter pylori</italic></article-title>. <source>Gastroenterology</source>. <year>2004</year>;<volume>127</volume>: <fpage>514</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2004.06.006</pub-id>
<pub-id pub-id-type="pmid">15300584</pub-id></mixed-citation></ref><ref id="pone.0227275.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Devi</surname><given-names>SM</given-names></name>, <name><surname>Ahmed</surname><given-names>I</given-names></name>, <name><surname>Khan</surname><given-names>AA</given-names></name>, <name><surname>Rahman</surname><given-names>SA</given-names></name>, <name><surname>Alvi</surname><given-names>A</given-names></name>, <name><surname>Sechi</surname><given-names>LA</given-names></name>, <etal>et al</etal>
<article-title>Genomes of <italic>Helicobacter pylori</italic> from native Peruvians suggest admixture of ancestral and modern lineages and reveal a western type cag-pathogenicity island</article-title>. <source>BMC Genomics</source>. <year>2006</year>;<volume>7</volume>: <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-7-1</pub-id><pub-id pub-id-type="pmid">16403227</pub-id></mixed-citation></ref><ref id="pone.0227275.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Argent</surname><given-names>RH</given-names></name>, <name><surname>Hale</surname><given-names>JL</given-names></name>, <name><surname>El-Omar</surname><given-names>EM</given-names></name>, <name><surname>Atherton</surname><given-names>JC</given-names></name>. <article-title>Differences in <italic>Helicobacter pylori</italic> CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion</article-title>. <source>J Med Microbiol</source>. <year>2008</year>;<volume>57</volume>: <fpage>1062</fpage>&#x02013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.2008/001818-0</pub-id>
<pub-id pub-id-type="pmid">18719174</pub-id></mixed-citation></ref><ref id="pone.0227275.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sicinschi</surname><given-names>LA</given-names></name>, <name><surname>Correa</surname><given-names>P</given-names></name>, <name><surname>Peek</surname><given-names>RM</given-names></name>, <name><surname>Camargo</surname><given-names>MC</given-names></name>, <name><surname>Piazuelo</surname><given-names>MB</given-names></name>, <name><surname>Romero-Gallo</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>CagA C-terminal variations in <italic>Helicobacter pylori</italic> strains from Colombian patients with gastric precancerous lesions</article-title>. <source>Clin Microbiol Infect</source>. <year>2010</year>;<volume>16</volume>: <fpage>369</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2009.02811.x</pub-id>
<pub-id pub-id-type="pmid">19456839</pub-id></mixed-citation></ref><ref id="pone.0227275.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Yamaoka</surname><given-names>Y</given-names></name>, <name><surname>Osato</surname><given-names>MS</given-names></name>, <name><surname>Sepulveda</surname><given-names>AR</given-names></name>, <name><surname>Gutierrez</surname><given-names>O</given-names></name>, <name><surname>Figura</surname><given-names>N</given-names></name>, <name><surname>Kim</surname><given-names>JG</given-names></name>, <etal>et al</etal>
<article-title>Molecular epidemiology of <italic>Helicobacter pylori</italic>: separation of <italic>H</italic>. <italic>pylori</italic> from East Asian and non-Asian countries</article-title>. <source>Epidemiol Infect</source>. <year>2000</year>;<volume>124</volume>: <fpage>91</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1017/s0950268899003209</pub-id>
<pub-id pub-id-type="pmid">10722135</pub-id></mixed-citation></ref><ref id="pone.0227275.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Occhialini</surname><given-names>A</given-names></name>, <name><surname>Marais</surname><given-names>A</given-names></name>, <name><surname>Urdaci</surname><given-names>M</given-names></name>, <name><surname>Sierra</surname><given-names>R</given-names></name>, <name><surname>Munoz</surname><given-names>N</given-names></name>, <name><surname>Covacci</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Composition and gene expression of the cag pathogenicity island in <italic>Helicobacter pylori</italic> strains isolated from gastric carcinoma and gastritis patients in Costa Rica</article-title>. <source>Infect Immun</source>. <year>2001</year>;<volume>69</volume>: <fpage>1902</fpage>&#x02013;<lpage>1908</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.3.1902-1908.2001</pub-id>
<pub-id pub-id-type="pmid">11179371</pub-id></mixed-citation></ref><ref id="pone.0227275.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Panayotopoulou</surname><given-names>EG</given-names></name>, <name><surname>Sgouras</surname><given-names>DN</given-names></name>, <name><surname>Papadakos</surname><given-names>K</given-names></name>, <name><surname>Kalliaropoulos</surname><given-names>A</given-names></name>, <name><surname>Papatheodoridis</surname><given-names>G</given-names></name>, <name><surname>Mentis</surname><given-names>AF</given-names></name>, <etal>et al</etal>
<article-title>Strategy To Characterize the Number and Type of Repeating EPIYA Phosphorylation Motifs in the Carboxyl Terminus of CagA Protein in <italic>Helicobacter pylori</italic> Clinical Isolates</article-title>. <source>J Clin Microbiol</source>. <year>2007</year>;<volume>45</volume>: <fpage>488</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01616-06</pub-id>
<pub-id pub-id-type="pmid">17151214</pub-id></mixed-citation></ref><ref id="pone.0227275.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Torres</surname><given-names>LE</given-names></name>, <name><surname>Gonz&#x000e1;lez</surname><given-names>L</given-names></name>, <name><surname>Meli&#x000e1;n</surname><given-names>K</given-names></name>, <name><surname>Alonso</surname><given-names>J</given-names></name>, <name><surname>Moreno</surname><given-names>A</given-names></name>, <name><surname>Hern&#x000e1;ndez</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>EPIYA motif patterns among Cuban <italic>Helicobacter pylori</italic> CagA positive strains</article-title>. <source>Biomedica</source>. <year>2012</year>;<volume>32</volume>: <fpage>23</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1590/S0120-41572012000100004</pub-id>
<pub-id pub-id-type="pmid">23235784</pub-id></mixed-citation></ref><ref id="pone.0227275.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Reyes-Leon</surname><given-names>A</given-names></name>, <name><surname>Atherton</surname><given-names>JC</given-names></name>, <name><surname>Argent</surname><given-names>RH</given-names></name>, <name><surname>Puente</surname><given-names>JL</given-names></name>, <name><surname>Torres</surname><given-names>J</given-names></name>. <article-title>Heterogeneity in the activity of Mexican <italic>Helicobacter pylori</italic> strains in gastric epithelial cells and Its association with diversity in the <italic>cagA</italic> gene</article-title>. <source>Infect Immun</source>. <year>2007</year>;<volume>75</volume>: <fpage>3445</fpage>&#x02013;<lpage>3454</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01951-06</pub-id>
<pub-id pub-id-type="pmid">17438024</pub-id></mixed-citation></ref><ref id="pone.0227275.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>R</given-names></name>, <name><surname>Shiota</surname><given-names>S</given-names></name>, <name><surname>Yamaoka</surname><given-names>Y</given-names></name>. <article-title>Molecular epidemiology, population genetics, and pathogenic role of <italic>Helicobacter pylori</italic></article-title>. <source>Infect Genet Evol</source>. <year>2012</year>;<volume>12</volume>: <fpage>203</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2011.12.002</pub-id>
<pub-id pub-id-type="pmid">22197766</pub-id></mixed-citation></ref><ref id="pone.0227275.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Argent</surname><given-names>RH</given-names></name>, <name><surname>Thomas</surname><given-names>RJ</given-names></name>, <name><surname>Aviles-Jimenez</surname><given-names>F</given-names></name>, <name><surname>Letley</surname><given-names>DP</given-names></name>, <name><surname>Limb</surname><given-names>MC</given-names></name>, <name><surname>El-Omar</surname><given-names>EM</given-names></name>, <etal>et al</etal>
<article-title>Toxigenic <italic>Helicobacter pylori</italic> infection precedes gastric hypochlorhydria in Cancer Relatives, and <italic>H</italic>. <italic>pylori</italic> virulence evolves in these families</article-title>. <source>Clin Cancer Res</source>. <year>2008</year>;<volume>14</volume>: <fpage>2227</fpage>&#x02013;<lpage>2235</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-2022</pub-id>
<pub-id pub-id-type="pmid">18381965</pub-id></mixed-citation></ref><ref id="pone.0227275.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Parkin</surname><given-names>DM</given-names></name>. <article-title>Global cancer statistics in the year 2000</article-title>. <source>Lancet Oncol</source>. <year>2001</year>;<volume>2</volume>: <fpage>533</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(01)00486-7</pub-id>
<pub-id pub-id-type="pmid">11905707</pub-id></mixed-citation></ref><ref id="pone.0227275.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Kalaf</surname><given-names>E</given-names></name>, <name><surname>Al-Khafaji</surname><given-names>Z</given-names></name>, <name><surname>Yassen</surname><given-names>N</given-names></name>, <name><surname>AL-Abbudi</surname><given-names>F</given-names></name>, <name><surname>Sadwen</surname><given-names>S</given-names></name>. <article-title>Study of the cytoxin-associated gene a (<italic>cagA</italic> gene) in <italic>Helicobacter pylori</italic> using gastric biopsies of Iraqi patients</article-title>. <source>Saudi J Gastroenterol</source>. <year>2013</year>;<volume>19</volume>: <fpage>69</fpage>
<pub-id pub-id-type="doi">10.4103/1319-3767.108474</pub-id>
<pub-id pub-id-type="pmid">23481132</pub-id></mixed-citation></ref><ref id="pone.0227275.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Bray</surname><given-names>F</given-names></name>, <name><surname>Ferlay</surname><given-names>J</given-names></name>, <name><surname>Soerjomataram</surname><given-names>I</given-names></name>, <name><surname>Siegel</surname><given-names>RL</given-names></name>, <name><surname>Torre</surname><given-names>LA</given-names></name>, <name><surname>Jemal</surname><given-names>A</given-names></name>. <article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. <year>2018</year>;<volume>68</volume>: <fpage>394</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21492</pub-id>
<pub-id pub-id-type="pmid">30207593</pub-id></mixed-citation></ref><ref id="pone.0227275.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Correa</surname><given-names>P</given-names></name>, <name><surname>Piazuelo</surname><given-names>MB</given-names></name>, <name><surname>Camargo</surname><given-names>MC</given-names></name>. <article-title>The future of gastric cancer prevention</article-title>. <source>Gastric Cancer</source>. <year>2004</year>;<volume>7</volume>: <fpage>9</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s10120-003-0265-0</pub-id>
<pub-id pub-id-type="pmid">15052434</pub-id></mixed-citation></ref><ref id="pone.0227275.ref033"><label>33</label><mixed-citation publication-type="book"><name><surname>Greenberger</surname><given-names>NJ</given-names></name>., <name><surname>Blumberg</surname><given-names>RS.</given-names></name>, <name><surname>Burakoff</surname><given-names>R</given-names></name>. <chapter-title>Diagn&#x000f3;stico y tratamiento en gastroenterolog&#x000ed;a, hepatolog&#x000ed;a y endoscopia</chapter-title>
<edition>7th ed.</edition>
<publisher-loc>M&#x000e9;xico D.F</publisher-loc>: <publisher-name>McGraw-Hill Interamericana</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="pone.0227275.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Malfertheiner</surname><given-names>P</given-names></name>, <name><surname>Megraud</surname><given-names>F</given-names></name>, <name><surname>O&#x02019;Morain</surname><given-names>CA</given-names></name>, <name><surname>Gisbert</surname><given-names>JP</given-names></name>, <name><surname>Kuipers</surname><given-names>EJ</given-names></name>, <name><surname>Axon</surname><given-names>AT</given-names></name>, <etal>et al</etal>
<article-title>Management of <italic>Helicobacter pylori</italic> infection&#x02014;the Maastricht V/Florence Consensus Report</article-title>. <source>Gut</source>. <year>2017</year>;<volume>66</volume>: <fpage>6</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2016-312288</pub-id>
<pub-id pub-id-type="pmid">27707777</pub-id></mixed-citation></ref><ref id="pone.0227275.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Fock</surname><given-names>KM</given-names></name>, <name><surname>Talley</surname><given-names>N</given-names></name>, <name><surname>Moayyedi</surname><given-names>P</given-names></name>, <name><surname>Hunt</surname><given-names>R</given-names></name>, <name><surname>Azuma</surname><given-names>T</given-names></name>, <name><surname>Sugano</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Asia&#x02013;Pacific consensus guidelines on gastric cancer prevention</article-title>. <source>J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>23</volume>: <fpage>351</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2008.05314.x</pub-id>
<pub-id pub-id-type="pmid">18318820</pub-id></mixed-citation></ref><ref id="pone.0227275.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Acosta</surname><given-names>N.</given-names></name>
<article-title><italic>Helicobacter pylori</italic> CagA protein polymorphisms and their lack of association with pathogenesis</article-title>. <source>World J Gastroenterol</source>. <year>2010</year>;<volume>16</volume>: <fpage>3936</fpage>
<pub-id pub-id-type="doi">10.3748/wjg.v16.i31.3936</pub-id>
<pub-id pub-id-type="pmid">20712055</pub-id></mixed-citation></ref></ref-list></back></article>